The Kennel Club has released a film, narrated by Clare Balding, which looks at the issues affecting dog health and wellbeing in this country and what is being done in 2012 to help ensure that dog welfare stays at the top of the agenda.

The film, 'Dogs - A Healthy Future', focuses on the main issues that affect dog health and welfare, including hereditary diseases, issues created by breeding dogs for the way that they look and the problem of cruel puppy farms that breed dogs for profit without regard for their health and welfare.

The film explores the steps that have already been taken to address these issues and the need for united action in order to ensure that the progress continues in 2012.

(The full 1/2 hour video is available here).

Caroline Kisko, Kennel Club Secretary, said: "The New Year is a good time for reflection, looking back at what has been done and what more can still be done to safeguard the health of dogs.

"Huge strides have been made to improve dog health, particularly with the knowledge that has been gained in recent years thanks to the advancement of genetic science, but there is still more to do. We particularly need to address the issue of people breeding dogs for money at the expense of health and for looks, whether these be pedigree or crossbreeds.

"The Kennel Club would like to see tighter regulations governing the way people breed their dogs in order to help clamp down on cruel puppy farms, and we ask people to sign our petition asking the government to act.

"As we look towards Crufts 2012 we look forward to introducing even tighter measures to ensure that dog shows play their part in driving change by rewarding, and so encouraging, the breeding of healthy dogs."

Sheila Crispin, Chairman of the Advisory Council on the Welfare Issues of Dog Breeding, said: "We are supposedly a nation of dog lovers and the issue of what we can do to improve dog health is close to the hearts of those that really do care. This film looks at the progress that has been made by the Kennel Club as well as other organisations and committed individuals to help address the complicated issues surrounding dog health and welfare, in addition to looking at what more needs to be done, through collaboration and united effort, to create an even better future for dogs."

The RCVS Disciplinary Committee has suspended a Co. Tyrone veterinary surgeon from the Register for ten months, having found him guilty of serious professional misconduct relating to three convictions for contravening animal export regulations.

Whilst working as an Authorised Veterinary Inspector in Castlederg for the Department of Agriculture and Rural Development (DARD), William Manson had falsely certified that he had inspected three consignments of sheep presented for assembly at Plumbridge Export Assembly Centre on 16 and 23 August 2009. At this week's two-day hearing, Mr Manson admitted that the convictions he had received at the Strabane Magistrates Court on 26 November 2010 made him unfit to practise veterinary surgery, but said in mitigation that he had examined the sheep nearby at Landahussy, a site he considered more suitable for a large number of animals.

The Committee was satisfied that Mr Manson believed the Landahussy site to be more suitable for large deliveries; the Committee also was satisfied that he did carry out a visual inspection of the sheep at the Landahussy site on 16 and 23 August 2009. However, the information Mr Manson provided on the three certificates was false and misleading. Mr Manson had also been reminded of the importance of complying with government regulations in a disciplinary case in 2004, following convictions for failing to notify DARD about changes in the number of sheep for which he was claiming a premium. The then Committee dismissed the case, deeming the convictions a result of his "genuine but regrettable oversight".

Speaking on behalf of the Committee, Chairman, Prof Peter Lees said: "Mr Manson's actions in certifying that he had examined the sheep at an approved assembly centre when he had not done so amounted to a serious departure from professional standards. If there had been a disease outbreak on either the Plumbridge or Landahussy site, such actions would have rendered contact tracings unreliable and inaccurate."

In mitigation, the Committee accepted medical evidence and Mr Manson's testimony that he was at that time under exceptional stress. He was working long hours in difficult circumstances without an assistant, and was under considerable personal pressure as a result of his wife's serious illness. It also took into account his age (66), exceptional testimonials produced on his behalf, and the impact on the community he served.

Prof Lees said: "The Committee has concluded that the removal of Mr Manson's name from the Register is neither proportionate nor necessary in the public interest nor to protect the welfare of animals. A proportionate sanction in this case is to suspend Mr Manson's name from the Register for a period of ten months."

Burgess Excel has launched The Excel Food Cube, billed as the first truly 'complete' food for rabbits and guinea pigs, aka 'fibrevores'.

According to the company, it's the first time that rabbit and guinea pig owners will be able to feed a convenient and portion controlled all-in-one food that caters for all of their pets' dental, digestive and emotional needs.

Historically, there has been debate as to whether any one food alone can be classed as 'complete' for these pets. Many foods on the market currently labelled 'complete' only meet the nutritional needs of these pets, because, historically in the world of dog and cat food, that's all a complete food needs to cater for. However, according to Burgess Excel, 72% of vets say that any food labelled as 'complete' for rabbits and guinea pigs should cover dental, digestive and emotional health. To be just 'nutritionally complete' is not enough, because diet accounts for so much more in keeping these pets alive and healthy.

Justin Heaton, Head of Marketing for Burgess Pet Care said "Once again we are incredibly excited and proud to be launching a pioneering new product to the market. Our studies revealed foods labelled 'complete' are generally fed alone, without the hay necessary for fibrevores.  As the UK's leading veterinary brand for fibrevores we felt obligated to create a truly healthy, 100% complete food to ensure that pets are being correctly fed. The additional beauty of this product is that it really drives home to fibrevore owners that hay IS food!

The Excel Complete Food Cubes consist of compressed cubes of long fibre Timothy hay for dental and digestive health, together with high fibre tasty nuggets, which contain short fibre, supplements and prebiotics, also necessary for digestive health and to promote foraging. Topped with flowers and beneficial herbs they deliver a visually exciting, innovative solution, inside and out for pet owners."

Justin continued "Excel was the first to expose the myth about 'complete feeds' and identify what the real requirements of these pets are, the first to develop a specific and dedicated feeding plan, the first to identify fibrevores as a subset of small animals and the first to campaign for complete diets to include dental, digestive and emotional health - all of which are why Excel is still the UK's No.1 veterinary recommended food for fibrevores.

However, in today's fast paced and busy world, consumers are always looking for the easiest, least hassle and most convenient ways to feed their pets. To date it has never been easy to find a solution to do this for fibrevores, without compromising their health........ that is until now!"

Burgess says Excel Food Cubes will be available in March but that more information and pre-orders can be taken from your local Burgess representative now. Alternatively, contact Justin Heaton for further information at: Justin.Heaton@burgesspetcare.co.uk

Elanco Animal Health has highlighted the results of a new study¹ which concludes that Duvaxyn IE-T Plus stimulates a highter protective antibody response than four other equine influenza vaccines commercially available in Ireland.

The trial compared the antibody responses of unvaccinated Thoroughbred weanlings following primary vaccination with Duvaxyn IE-T Plus, Equilis Resequin, Equip FT, Equilis Prequenza Te and  ProteqFlu Te.

In addition, following the first vaccination, 43% of the weanlings failed to seroconvert. However, amongst those vaccinated with Duvaxyn IE-T Plus a 100% response rate was observed. The failure rate amongst vaccines other than Duvaxyn IE-T Plus ranged between 7.7% and 78.6%. By the time of the third vaccination (31 weeks after the first) all horses had responded to vaccination.

The study, conducted by the Irish Equine Centre in Johnstone, the Department of Life Sciences at the University of Limerick and the Department of Statistics at Trinity College in Dublin, involved 66 unvaccinated Thoroughbred weanlings on four different stud farms. Following primary vaccination (V1, V2 and V3) with the five vaccines antibody responses were monitored for six months post V3 by single radial haemolysis. Elanco says that the correlation between SRH antibody levels and protection has been well-established and accepted².

Elanco also highlights a recent study³ which it says demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course. The company says that this is believed to be the first demonstration of cross protection by a current UK equine influenza vaccine against a Florida sub-lineage clade 2 reference strain.

Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "Most studies carried out by vaccine companies take place under controlled conditions that are optimal for effective vaccination.  This latest study shows how well Duvaxyn IET plus stimulates immunity under field conditions against both vaccinal and non-vaccinal strains. Importantly, all the weanlings vaccinated with Duvaxyn seroconverted after the first vaccination, conferring earliest and most reliable protection for these vulnerable animals."

For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 779881.

References:

• 1. Gildea, S et al. Vaccine 29 (2011) 9214-9223
• 2. Mumford JA et al. Epidemiol Infect. (1994) 112: 421-437.
• 3. ECAH study: AHT study ID C012/01

Ticks infected with the bacteria that cause Lyme disease may be considerably more prevalent in the UK than recent estimates indicate, according to new research from the University of Bristol that used pet dogs as 'sentinels' for human disease risk.

Transmitted by ticks, Lyme disease is a debilitating chronic infection which affects a number of animals including humans and dogs. It is caused by the bacterium Borrelia burgdorferi. Clinical signs in humans include a characteristic circular red rash that spreads from the site of the tick bite, followed by a flu-like condition. In dogs, the symptoms can be much more vague and difficult to diagnose. If untreated, the disease progresses to neurological problems and arthritis; chronic forms of the disease can last for many years.

While only occasionally affecting humans, reported cases in the UK are thought to have increased more than fourfold since the beginning of the century - from 0.38 per 100,000 in 2000 to 1.79 per 100,000 in 2009. In 2010 there were 953 reported cases in England and Wales but the level of under-reporting is likely to be considerable.

To obtain a clearer picture of the prevalence of infected ticks, Faith Smith of Bristol's School of Biological Sciences and colleagues recruited veterinary surgeons across England, Scotland and Wales to examine dogs selected at random as they visited veterinary practices. Since pet dogs largely share the same environment and visit the same outdoor areas as their owners, exposure to infected ticks in dogs is likely to provide an index for corresponding risks to humans.

Of 3,534 dogs inspected between March and October 2009, 14.9% had ticks. Of the samples that could be tested, 17 (2.3%) were positive for the Borrelia bacteria. The expected prevalence of infected ticks on dogs is 0.5 per cent, or 481 infected ticks per 100,000 dogs. This suggests that the prevalence of Borrelia in the UK tick population is considerably higher than previously thought.

Faith Smith said: "Lyme disease appears to be a rapidly growing problem in the UK with important health and economic impacts in terms of loss of working hours and potential decrease in tourism to tick hotspots.

"Without considerably better surveillance and routine diagnostic testing, Lyme disease is only likely to become more prevalent. In particular, future warmer winters might well extend the period over which ticks are active seasonally, while growing wild reservoir host populations, such as deer, will allow the tick population to expand."

The study is published today in the journal Comparative Immunology, Microbiology and Infectious Diseases. The research was funded by the Natural Environment Research Council (NERC) and Merial Animal Health Ltd.

The British Veterinary Association has reiterated its call for heightened vigilance following confirmation by AHVLA that Schmallenberg virus (SBV) has been detected on four sheep farms in Norfolk, Suffolk and East Sussex.

At this early stage the virus is understood to be vector-borne (although other routes of transmission have not been ruled out) and the clinical signs seen along with meteorological modelling of risk suggests that the four farms were affected during summer/autumn 2011, with congenital defects now becoming visible at lambing time.

Animals imported from the affected areas in northern Europe are also considered to be potentially at risk and their destination in the UK has been identified.

Congenital deformities and nervous defects are seen in newborn lambs, goat kids and calves. Clinical signs in affected cattle include pyrexia (fever), milk drop, and diarrhoea similar to what is often termed 'winter dysentery'. Farmers should be looking out for clusters of these signs within herds and flocks and reporting them to their veterinary surgeon.

Vets who are aware of suspicious clinical signs on their client's farms should report them to AHVLA, SAC or the local DARD divisional veterinary office for further investigation.

AHVLA, SAC and DARD have stated that they are keen to investigate potential cases and there will be no extra charge for the SBV tests that are undertaken, but their approaches are slightly different.

In England, Wales and Northern Ireland AHVLA and AFBI are carrying out SBV-only testing (ie to rule the disease in or out) free of charge but are charging the standard subsidised investigation charge for any additional diagnostic work.

In Scotland any carcases submitted for post mortem examinations are examined at the standard fee and all necessary examinations required by the VIO to investigate the case are included in the fee. SAC is not charging an additional fee for SBV testing.

Carl Padgett, President of the BVA, said:  "The confirmation of Schmallenberg virus in sheep flocks in England is a reminder to vets and farmers across the UK to step up vigilance amongst ruminants.

"The BVA would encourage vets to speak to their local AHVLA, SAC or DARD team to discuss any suspect cases and consider submitting specimens for further investigation. We understand that in confirmed cases clinical signs occur in clusters and vets should ensure they know what to look for in both adult and perinatal ruminants.

"While the cases in the south east of England suggest the virus is vector-borne other potential routes of transmission are still being considered. Although the risk of zoonosis is believed to be very low it has not been ruled out and a sensible precautionary approach should be taken by those handling infected animals and specimens."

Kruuse has launched a new extra large size Bovivet Hoof Bandage for use in the treatment of digital dermatitis (DD) in cattle.

According to the company, an estimated 70 per cent of dairy herds suffer with digital dermatitis and, if not treated, it can persist for months, causing pain and lameness to infected cows. Indeed, a paper¹ presented at the BCVA 2011 Congress by Prof. N.B. Cook, Clinical Associate Professor at the School of Veterinary Medicine in Madison, USA, said that "lameness can systematically undermine the management of the dairy herd. No other disease has such fundamental and extensive effects on production, reproduction and risk of early herd removal."

The most effective way to fight DD has been found to be the management and treatment of individual animals. Traditional treatments have involved thoroughly washing the infected hoof, applying an antibiotic/drying agent, such as salicylic acid powder, and then applying a dressing that must remain in place usually for three days. However, it can be hard to correctly dose the salicyclic acid powder and there can be complications in ensuring that the dressing is correctly applied at the right pressure and that it stays in place. It can also be a risk to the user's health when mixing the powder.

Kruuse says this can be made easier by using the Bovivet complete Hoof Bandage along with Kruuse Hoof Gel 38%. Firstly, by using a gel, dosing is easy and more accurate, making it more economical per treatment; and, secondly, for the user, it reduces potential health risks from inhalation of the powder when mixing.

Stuart Wilson from Kruuse UK said: "Since the launch in the UK early last year, the hoof bandage has been very well received by cattle vets, but we were told by them that a larger version was needed in some cases. So Kruuse has produced the new extra large size 'red Jimmy Choos for moos'!"

Kruuse has produced the following instructional video to demonstrate the products' ease of use and versatility, and says that the estimated cost per hoof, assuming ten treatments from a bottle of the gel, is £2.71.

Reference

1. "Finding solutions to lameness problems in dairy herds", Cook,N.B., Clinical Associate Professor in Food Animal Production Medicine, School of Veterinary Medicine, University of Wisconsin-Madison, Madison WI53706, USA

Diverse Undertakings Ltd. has announced that it is extending its services to include support for veterinary practices in securing their RCVS Practice Standards Scheme (PSS) accreditation.

The company was originally formed to provide business advisory services to small and medium sized enterprises across a range of industry sectors. Its services range from general H.R. advice, health & safety guidance and facilities management to candidate sourcing and call-centre services.

However, with previous experience supporting a substantial veterinary practice in Kent for both employment challenges and PSS accreditation, Company Director Neal Palk decided to extend the company's capability to support other veterinary practices in securing their PSS accreditation.

He says that because the needs of each practice vary, Diverse can adapt its service to reflect both the individual circumstances relating to accreditation as well as the capability/capacity with the practice to undertake necessary tasks itself. By using a network of associates, he says Diverse can call upon other specialities (for example - competitively priced office/building equipment) to smooth the progress to accreditation.

Diverse says it offers a range of transparent pricing options to suit the client which, without the overheads of large consultancies, often result in PSS accreditation being achieved for less cost than a typical administrative temp for a month. Monthly retention fee alternatives for other services are available, beginning at £95+ VAT.

Neal said: "Several organisations offer professional services to the veterinary practice sector, but few can claim to have 'been there, done that' and really understand the climate and culture the sector operates within. Diverse Undertakings Ltd. values its experience in the sector and aims to work with other practices to achieve both accreditation and wider business success."

For more details please contact Neal on 07771 843719, e-mail: info@diverseundertakings.com, or visit: http://www/diverseundertakings.com

In case you missed the email last month, Novartis Animal Health has announced the launch of Atopica for Cats (cyclosporine oral solution, 100 mg/ml), a treatment for chronic allergic dermatitis.

This disease, which is apparently one of the most common reasons for pet owners to take cats to the veterinary surgeon², can be difficult to diagnose and causes itching and associated chewing and licking, skin lesions and loss of hair. Atopica for Cats is the first medication approved in the UK specifically for allergic dermatitis in cats.

Novartis says the new product provides relief from the uncomfortable and recurrent itch/scratch cycle, and the majority of improvements are seen in the first four weeks^3-5. The company also says that in clinical trials, 84 per cent of cats diagnosed with allergic dermatitis were considered to be "uncomfortable" at the start of the study⁵. After six weeks of treatment with Atopica for Cats, 78 per cent of cats were considered "comfortable" with satisfactory levels of grooming³ - a key indicator of a healthy cat. Additionally, Atopica for Cats is proven to significantly reduce unsightly and painful skin lesions and has a proven safety profile.

Anne-Laure Driscoll, Atopica Brand Manager, Novartis Animal Health UK, said: "Veterinarians and pet owners understand the discomfort and frustration of an itchy pet. We are pleased to add Atopica for Cats to our proven family of Atopica products, offering an effective treatment for cats suffering from the extreme discomfort associated with allergic dermatitis."

Developed specifically for domestic felines, Atopica for Cats is an oral solution which Novartis says is easy-to-dose and administer. In studies, approximately one-third of cats took the medicine in their food and two-thirds were dosed directly into the mouth^3,4. According to the company, the product offers a unique mode of action that specifically targets immune cells such as the T-lymphocytes involved in the allergic reaction. In this way, Atopica for Cats blocks the production of inflammatory cytokines, molecules that fuel the allergic response, breaking the recurrent itch/scratch cycle.

Dr. Keith Hnilica, DVM, MS, MBA and DACVD, and author of Small Animal Dermatology: A Color Atlas and Therapeutic Guide (3rd ed), said: "Atopica for Cats has the potential to change how our profession treats the itchy cat. For the first time ever, we have a safe, highly effective, approved treatment for cats with allergic dermatitis. And because Atopica for Cats is not a corticosteroid, I can prescribe it for long-term use without worrying about the health risks that can be associated with steroids."

References

1. Atopica for Cats is indicated for symptomatic treatment of chronic allergic dermatitis in cats in the EU, and for control of feline allergic dermatitis in the US.
2. Veterinary Practice News, April 2011: Veterinary Pet Insurance (VPI), top 10 pet medical conditions of 2010, p10.
3. Novartis data on file. Study summary CYCINT-0105.
4. Novartis data on file. Study summary CYCINT-0205.
5. Novartis data on file. Study summary NAH-07-0028.
6. Lowe AD et al. Glucocorticoids in the cat. Vet Derm, 2008, 19, 340-347

Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.

The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.

Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.

Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.

Vetoquinol UK Ltd has launched a new flea and tick treatment for cats and dogs.

Flevox is a spot-on solution containing fipronil and comes in unique pack sizes of either single pipettes or large clinic packs of 36.

Product Manager Helen Walker said: "With only 55% of pet owners buying their flea and tick treatment from the vet, we recognise there is a huge opportunity to develop and grow this essential market.  In the modern age the consumer expects maximum flexibility, and that is what we aim to provide with Flevox.

Whether it be persuading the price-conscious customer away from buying their flea treatments in supermarkets and the internet, or encouraging those who don't treat their pet at all to give it a try without breaking the bank, we're confident we can help grow flea treatment sales in practice."

Vetoquinol says it is supporting the new product with a range of materials dedicated to veterinary surgeries, providing incentives to encourage client bonding and repeat business with your practice.

Helen continued: "We have also teamed up with the fantastic charity Dogs for the Disabled by making a donation for every pipette of Flevox sold.  We're really looking forward to raising the profile of this organisation where these amazing dogs give life changing independence to disabled people.  We're confident the donation will strike a chord with clients and really engage them with the charity, the Flevox brand and the practice".

To find out more, contact your Vetoquinol territory manager or visit http://www.vetoquinol.co.uk/ 

Bayer Animal Health has launched a new version of Drontal which is presented as a bone-shaped tablet.

The company says that this is the UK's first worming tablet shaped like a bone, and that the product is designed to help improve client compliance.

Dan White, Group Product Manager at Bayer Animal Health said: "Almost half of dog owners - surveyed prior to launch - indicated that new Drontal bone would encourage them to worm their dogs more routinely. This is clearly great news for practices especially during these difficult economic times.

The launch of Drontal bone will be supported by a marketing drive that includes a new advertising creative concept which will be featured as part of a national TV advertising campaign, and an online consumer-facing competition called Give Your Dog A Bone designed to engage further with dog owners and communicate the benefits of having a worm-free dog.

Dan added: "The online and supporting consumer PR campaign will bring to life the special bond between pet and owner, and celebrate the happiness that dogs bring to our lives when they are happy, healthy and worm-free."

Practices can request a practice support pack to promote the availability of Drontal bone which will include a notice board picture-pack aimed at dog owning clients by calling their Bayer Territory Manager or 01635 563380.

The Give Your Dog a Bone competition and PR campaign has been devised by leading healthcare communications agency Pegasus. The new 'bone-shaped' TV and print creative has been developed by the recently-appointed advertising agency Dinosaur and will launch in early 2012.

Drontal's Give Your Dog a Bone competition will be launched on 1st March 2012 at www.giveyourdogabone.co.uk.